MedTrace Pharma A/S: Financial statements 2015
CVR: 36497661
Source: annual report 2015, Danish Business Authority
05/01/2015 – 31/12/2015
MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -232,409,000 and a net result of DKK -245,485,000. Equity in the 2015 report amounted to DKK 2,754,628,000. The solvency ratio was 89.4%.
- Gross Profit
- DKK -232,409,000
- Profit/Loss
- DKK -245,485,000
- Equity
- DKK 2,754,628,000
- Total Assets
- DKK 3,082,716,000
Official annual report
How creditworthy is MedTrace Pharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
On December 17, 2015, the company changed its name from Medtrace ApS to MedTrace A/S.
As of October 5, 2015, KPMG P/S has been appointed auditor of MedTrace Pharma A/S.
As of October 5, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MedTrace Pharma A/S.
As of October 5, 2015, Bjarne Henning Jensen has joined the board of directors of MedTrace Pharma A/S.
As of October 5, 2015, Mads Spangaard Rasmussen has joined the board of directors of MedTrace Pharma A/S.
As of October 5, 2015, Bernt Skov Jensen has joined the board of directors of MedTrace Pharma A/S.
As of October 5, 2015, Peter Larsen has stepped down as director of MedTrace Pharma A/S.
As of October 5, 2015, Rune Wiik Kristensen has stepped down as director of MedTrace Pharma A/S.
On October 5, 2015, the company changed its name from LSW MEDICAL IVS to Medtrace ApS.
As of January 5, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MedTrace Pharma A/S.
About MedTrace Pharma A/S
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.